FMC Huntsville is a medicare approved dialysis facility center in Huntsville, Alabama and it has 31 dialysis stations. It is located in Madison county at 2325 Pansy Street, Huntsville, AL, 35801. You can reach out to the office of FMC Huntsville at (256) 536-1881. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Huntsville has the following ownership type - Profit. It was first certified by medicare in August, 1985. The medicare id for this facility is 012522 and it accepts patients under medicare ESRD program.
| Name | FMC Huntsville |
|---|---|
| Location | 2325 Pansy Street, Huntsville, Alabama |
| No. of Dialysis Stations | 31 |
| Medicare ID | 012522 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 2325 Pansy Street, Huntsville, Alabama, 35801 | |
| (256) 536-1881 | |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
| NPI Number | 1588776314 |
| Organization Name | Huntsville Dialysis Center |
| Doing Business As | Bio-medical Applications Of Alabama, Inc. |
| Address | 2325 Pansy St Sw Huntsville, Alabama, 35801 |
| Phone Number | (256) 536-1881 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
| Dialysis patients with Hemoglobin data | 37 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 30 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 68 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 553 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
| Adult patients getting regular peritoneal dialysis at the center | 1 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 12 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Huntsville with elevated calcium levels.
| Patients with hypercalcemia | 73 |
| Hypercalcemia patient months | 593 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 77 |
| Patients with Serumphosphor less than 3.5 mg/dL | 8 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 25 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 16 |
| Patients with Serumphosphor greater than 7 mg/dL | 18 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 74 |
| Patient months included in arterial venous fistula and catheter summaries | 522 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 65 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 10 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 66 |
| Hospitalization Rate in facility | 129.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 265.5 |
| Hospitalization Rate: Lower Confidence Limit | 66 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC Huntsville were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 19.5 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 37.8 |
| Readmission Rate: Lower Confidence Limit | 7.5 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC Huntsville get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .32 (As Expected) |
| SIR: Upper Confidence Limit | 1.57 |
| SIR: Lower Confidence Limit | .02 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC Huntsville's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 59 |
| Transfusion Rate in facility | 27.1 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 102.9 |
| Transfusion Rate: Lower Confidence Limit | 8.4 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
The rate of mortality show you whether patients who were being treated regularly at FMC Huntsville lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 478 |
| Mortality Rate in facility | 20.6 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 26.4 |
| Mortality Rate: Lower Confidence Limit | 15.7 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago
FMC North Alabama Location: 1311 N Memorial Pkwy #200, Huntsville, Alabama, 35801 Phone: (256) 536-8571 |
News Archive
As a nurse manager for one of Chicago's busiest safety-net hospitals, Raquel Prendkowski has witnessed covid-19's devastating toll on many of the city's most vulnerable residents — including people who lack health insurance because of their immigration status. Some come in so sick they go right to intensive care. Some don't survive.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Preliminary results of a pre-specified subgroup study analysis of patients with diabetes and hypertension demonstrated that the investigational triple combination therapy of olmesartan medoxomil / amlodipine / hydrochlorothiazide (40/10/25 mg) resulted in a statistically significant greater Least Squares mean reduction in blood pressure from baseline at week 12 (37.9/22.0 mm Hg versus 26.4-28.0/14.7-17.6 mm Hg, P less than or equal to 0.0013) as compared to corresponding dual combination therapy [olmesartan medoxomil (40 mg) / amlodipine (10 mg); olmesartan medoxomil (40 mg) / hydrochlorothiazide (25 mg); or amlodipine (10 mg) and hydrochlorothiazide (25 mg)].
INTEGRA's VOYAGER adjustable tip spacing pipette and VIAFLO lightweight electronic pipette are the perfect lab companions for agricultural research into microbial evolution.
› Verified 6 days ago